Obesity Medicare - Search News

Medicare should cover Wegovy — but not negotiate its price

Former Trump health official: Medicare should cover Wegovy — but not negotiate its price

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 weight-loss drugs — but says subjecting Wegovy to price controls is a bad move.

The New York Times · 15h

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

CBS News · 15h

Medicare drug price negotiations to target Ozempic, Wegovy and other drugs

The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

9hon MSN

Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drug Ozempic

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

13h

Ozempic, Wegovy among drugs selected for Medicare's price negotiations

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

9hon MSN

This Week in Medicare & Social Security - Jan. 13-17, 2025

Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results